Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
OpenAI in talks with Samsung to power AI features, report says
-
4
Two jailed for forcing disabled teens into prostitution
-
5
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
S. Korea not to attend Sado mine memorial: foreign ministry
-
8
South Korean military plans to launch new division for future warfare
-
9
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
10
North Korean leader ‘convinced’ dialogue won’t change US hostility
IntRon Biotechnology to issue stocks for US$23.7m capital increase
By 황유미Published : July 5, 2016 - 17:07
[DISCLOSURE] IntRon Biotechnology (048530) has decided on a 27.2 billion won (US$23.7 million) capital increase with third party allotment to secure fund for R&D. The company will issue 15 million shares at 500 won each.
